The Virginia Commonwealth University researchers behind one of the most widely-used canine Lyme disease vaccines are developing a human version of the technology, with an eye toward future ...
Luxturna was the first FDA-approved gene therapy for a disease caused by mutations in a specific gene. It helped establish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results